Veritas Pharma Inc.
Veritas Pharma Inc.
Veritas has developed intellectual property and clinical data relating to various cannabis strains and products. It is the Company’s aim to advance the science behind medicinal cannabis, by developing cannabis-based treatments for specific disease conditions. The Company is also focused on investigating opportunities to acquire income-producing assets in the cannabis industry. Moreover, Veritas intends to leverage its management expertise to enter into mergers and acquisitions with suitable cannabis-industry participants, with a view to generating revenue while continuing its research and development opportunities.
Veritas Pharma Inc. (VRT)
SEDAR Information
Company Info
Capitalization
Company Officers
News Releases
News Release
News Release
Bulletins
2021-0909 - Reinstatement – Veritas Pharma Inc. (VRT)
Le 9 septembre/September 2021
Effective immediately, Veritas Pharma Inc. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
____________________________
À compter de maintenant Veritas Pharma Inc. sera rétablie à des fins de négociation.
La Société a rectifié la situation de défaut ayant donné lieu à la suspension.
Advertisement
Publicité
Upcoming Events
2021 Nation Builder of the Year Award
Thursday, December 9, 2021 -
Vancouver Resource Investment Conference (VRIC)
90th Annual PDAC Convention 2022
